G Scott Drew – 2019 Dermatology Update for the PCP
Salepage : G Scott Drew – 2019 Dermatology Update for the PCP
Presentation Title: Diagnostic & Therapeutic Update in Dermatology
Presentation Objectives: 1. Recognize new options in squamous cell sarcoma. 2. Understand diagnostic changes in melanoma. 3. Discuss new therapeutic options in psoriasis.
The Maine Osteopathic Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.The Maine Osteopathic Association designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Scott Drew, DO, FAOCD, FAAD, “Geriatric Dermatology,” is a practicing physician with Smith Clinic, Department of Dermatology in Marion, Ohio; faculty for the dermatology residency program at Ohio University College of Osteopathic Medicine in Athens, Ohio; and adjunct clinical faculty for the Ohio State University College of Medicine and Public Health in Columbus, Ohio. Board certified in dermatology and family medicine, he is a 1987 graduate of Kirksville (Mo.) College of Osteopathic Medicine. Dr. Drew completed an internship at Normandy Osteopathic Hospitals in St. Louis, Missouri, a family medicine residency at the University of Medicine and Dentistry of New Jersey in Camden, and a dermatology residency at Deaconess Medical Center, North and West in St. Louis, Missouri. A fellow of the American Osteopathic College of Dermatology and the American Academy of Dermatology, he is past president of the Marion Academy of Medicine and a member of the American Osteopathic Association, the Ohio Osteopathic Association, the Ohio State Medical Association, the Ohio Dermatologic Association, the Central Ohio Dermatologic Society, the Ohio Dermatologic Surgery Association and the Society of Dermatologic Physician Assistants. Disclosure: Independent Contractor/Consultant/Speaker’s Bureau/Advisory Committee for AbbVie, Inc.; Ortho Pharmaceutical Corp.; UCB; Incyte Corp.; Dermavant Sciences, Ltd.; and Boehringer Ingelheim.
